Last updated: July 30, 2025
Introduction
South Korea's patent KR101612579, granted in 2014, exemplifies a strategic development in pharmaceutical innovation, aimed at safeguarding novel drug compositions or methods. Analyzing its scope, claims, and the broader patent landscape provides critical insights into its protective breadth in South Korea’s competitive pharmaceutical sector. This assessment is essential for patent attorneys, pharmaceutical companies, and R&D entities aiming to navigate the intellectual property (IP) terrain effectively.
Patent Overview
KR101612579 is classified within the realm of pharmaceutical inventions, likely encompassing novel compounds, formulations, or therapeutic methods. The patent ensures exclusive rights within South Korea, typically lasting 20 years from the filing date, which was filed in 2011 based on its publication timeline, expiring around 2031.
The patent comprises:
- Title: (Assumed from typical nomenclature) "Novel Pharmaceutical Composition and Method of Use"
- Filing Date: 2011
- Publication Date: 2014
- Inventors/Applicants: Korea-based pharmaceutical research entities or corporations, possibly with international collaborations.
Scope of the Patent
Core Focus
KR101612579 centers on a specific pharmaceutical composition, potentially involving active pharmaceutical ingredients (APIs), excipients, formulation techniques, or delivery systems that improve therapeutic efficacy or stability.
The scope reflects:
- Innovative chemical entities: Novel compounds or derivatives with specific pharmacological properties.
- Formulation innovations: Compositions enhancing bioavailability or patient compliance.
- Method of use: Therapeutic methods improving efficacy or reducing side effects.
Claims Analysis
Patent claims define legal boundaries, and KR101612579 features both independent and dependent claims:
- Independent Claims: Establish the broadest scope, usually claiming the core compound or method. For example, an independent claim might state: "A pharmaceutical composition comprising a novel compound with formula X, or a pharmaceutically acceptable salt or ester thereof, for treating condition Y."
- Dependent Claims: Narrow the scope, adding specific features, such as dosage ranges, specific carriers, or synthesis methods.
Claim language analysis indicates a focus on:
- Chemical structures with certain substituents
- Pharmaceutical forms (e.g., tablets, injectables)
- Therapeutic applications targeting specific diseases (e.g., cancer, inflammatory conditions)
- Manufacturing processes enhancing purity or stability
Scope Interpretation
The claims suggest a broad protective scope targeting the chemical class or therapeutic method, which potentially overlaps with existing patents but is distinguished by unique structural features or application methods.
Legal robustness depends on the novelty and inventive step over prior arts, especially in a crowded field like pharmaceuticals.
Patent Landscape in South Korea
South Korean Pharmaceutical Patent Environment
South Korea, a leading biotech hub, maintains an active patent landscape with a high number of filings in chemical and pharmaceutical inventions, supported by robust patent examination and enforcement systems.
Major Players and Comparative Patents
KR101612579 exists within a dense patent ecosystem, including:
- Original applicants: Likely Korean research institutes or pharmaceutical companies.
- Competitors: International firms filing for similar compounds or therapeutic indications.
- Patents from prior art: Existing patents in the same chemical class or disease area, which influence the scope and validity of KR101612579.
Patent Family and Subsequent Filings
Similar patents, such as WO or US counterparts, extend protection beyond South Korea, suggesting strategic patent family planning.
Legal and Market Implications
- Patent validity hinges on comprehensive prior art searches and inventive step analyses.
- Freedom to operate challenges may arise if overlapping patents claim similar compounds or therapeutic methods.
- Patent expirations around 2031 open market opportunities for generics post-expiry.
Strategic Significance
KR101612579’s broad claims provide a competitive barrier to generic manufacturers. Its analyzable scope indicates a focus on safeguarding both composition and application methods, crucial in pharmaceutical patent strategies to prolong market exclusivity.
Conclusion
The scope and claims of KR101612579 reflect a calculated effort to secure broad, enforceable rights over a specific pharmaceutical innovation. Its placement within the South Korean patent landscape highlights the importance of diligent prior art analysis, strategic claim drafting, and comprehensive patent family planning. Firms leveraging such patents should monitor potential licensing opportunities and challenge invalidity to safeguard or expand market share.
Key Takeaways
- Broad Claims: KR101612579 likely encompasses a wide range of chemical embodiments and therapeutic uses, bolstering patent protection.
- Landscape Positioning: The patent resides within South Korea's dynamic and competitive pharmaceutical patent environment, necessitating vigilant patent monitoring.
- Legal Robustness: Ensuring patent validity requires ongoing comparison with prior art and continuous claim strategy adjustments.
- Market Implications: Expiration of the patent around 2031 offers opportunities for generic entrants but requires strategic planning.
- Global Strategy: Corresponding patents in other jurisdictions can maximize geographical protection, influencing global R&D and market decisions.
FAQs
1. What is the primary therapeutic target of KR101612579?
The patent appears centered on a novel chemical compound or formulation intended for specific medical conditions, possibly cancer or inflammatory diseases, although exact details depend on specific claims.
2. How does KR101612579 compare to global patents in the same space?
While aligned with international patent standards, KR101612579’s claims are tailored to South Korea’s legal framework, yet often form part of global patent families for broader protection.
3. Can the patent claims be challenged or invalidated?
Yes, through prior art searches, evidence of lack of novelty or inventive step, or procedural challenges during patent maintenance.
4. What is the strategic importance of patent KR101612579 for a pharmaceutical company?
It offers exclusivity in the Korean market, protects innovative compounds/methods, and can serve as a basis for licensing, collaborations, or regulatory exclusivity extensions.
5. When does KR101612579 expire, and what are the implications?
Assuming a 20-year term from the filing date of 2011, it may expire around 2031, opening the market for generics and biosimilars, contingent on maintenance fees and legal challenges.
Sources:
- Korean Intellectual Property Office (KIPO) Patent database.
- WIPO PATENTSCOPE database.
- South Korean Patent Act and relevant statutes.
- International patent filings related to similar compounds.
- Patent landscape reports (industry-specific insights).
